503067-83-2

Basic information

• Product Name: 3-Pyrrolidinamine,1-(cyclopropylmethyl)-N-methyl-(9CI)
• Synonyms: 3-Pyrrolidinamine,1-(cyclopropylmethyl)-N-methyl-(9CI)
• CAS NO: 503067-83-2
• Molecular Formula: C9H18N2
• Molecular Weight: 154.25262
• Product Categories: AMINETERTIARY
• Mol File: 503067-83-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Pyrrolidinamine,1-(cyclopropylmethyl)-N-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyrrolidinamine,1-(cyclopropylmethyl)-N-methyl-(9CI)(503067-83-2)
• EPA Substance Registry System: 3-Pyrrolidinamine,1-(cyclopropylmethyl)-N-methyl-(9CI)(503067-83-2)

Safety Data

• Hazardous Substances Data: 503067-83-2(Hazardous Substances Data)

Upstream product

• 186550-13-0 3-amino-1-(t-butoxycarbonyl)pyrrolidine 
• 325775-36-8 tert-butyl 3-{[(benzyloxy)carbonyl]amino}-1-pyrrolidinecarboxylate 

Relevant articles and documents

Discovery of quinazoline-2,4(1: H,3 H)-dione derivatives as novel PARP-1/2 inhibitors: Design, synthesis and their antitumor activity

Novel quinazoline-2,4(1H,3H)-dione derivatives bearing a 3-amino pyrrolidine moiety were designed and synthesized as PARP-1/2 inhibitors. Structure-activity relationships were examined which revealed a number of potent PARP-1/2 inhibitors with moderate se

3-amino nafoxidine-containing quinazoline ketone PARP (Poly Adenosine Diphosphate Ribose Polymerase)-1/2 inhibitor as well as preparation method, medicinal composition and application thereof

The invention discloses a novel 3-amino nafoxidine-containing quinazoline-2,4(1H, 3H)-diketone PARP-1/2 (Poly Adenosine Diphosphate Ribose Polymerase) inhibitor as well as a preparation method, a medicinal composition and application thereof. Specifically, the invention relates to a 3-amino nafoxidine-containing quinazoline-2,4(1H, 3H)-diketone derivative and a medicinal salt thereof of formula (I) as shown in the specification, a preparation method thereof, a composition with one or more such compounds, preparation of the compounds, and application thereof in preparing medicines for preventing and/or treating PARP-1/2 related diseases.